Page 1 de 42 résultats
REFERENCES
Fito M, Guxens M, Corella D, Saez G, Estruch R, de la Torre R, Frances F, Cabezas C, Lopez-Sabater Mdel C, Marrugat J, Garcia-Arellano A, Aros F, Ruiz-Gutierrez V, Ros E, Salas-Salvado J, Fiol M, Sola R, Covas M I. (2007). Effect of a traditional Mediterranean diet on lipoprotein
REFERENCES
[1] Fito M, Guxens M, Corella D, Saez G. Estruch R, de la Torre R, Frances F, Cabezas C, Lopez-Sabater Mdel C, Marrugat J, Garcia-Arellano A, Aros F, Ruiz-Gutierrez V, Ros E, Salas-Salvado J. Fiol M. Sola R, Covas M I. (2007). Effect of a traditional Mediterranean diet on lipoprotein
FIELD OF THE INVENTION
The invention in general relates to therapeutic management methods for hypercholesterolemia. More specifically, the present invention relates to the management of hypercholesterolemia in mammalian subjects using therapeutically effective amounts of Calebin A.
BACKGROUND OF THE
FIELD OF THE INVENTION
The invention in general relates to therapeutic management methods for hypercholesterolemia. More specifically, the present invention relates to the management of hypercholesterolemia in mammalian subjects using therapeutically effective amounts of Calebin A.
BACKGROUND OF THE
DESCRIPTION
Background of the Invention
Field of the Invention
The invention generally relates to lipid-lowering therapies. In particular, the invention provides a nuclear cholesterol metabolite, 5-cholesten-3.beta., 25-diol 3-sulphate, that decreases lipid biosynthesis and increases cholesterol
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention generally relates to lipid-lowering therapies. In particular, the invention provides a nuclear cholesterol metabolite, 5-cholesten-3.beta., 25-diol 3-sulphate, that decreases lipid biosynthesis and increases cholesterol secretion
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention generally relates to lipid-lowering therapies. In particular, the invention provides a nuclear cholesterol metabolite, 5-cholesten-3.beta., 25-diol 3-sulphate, that decreases lipid biosynthesis and increases cholesterol secretion
FIELD OF THE INVENTION
The present invention relates to compounds that are inhibitors of the microsomal triglyceride transfer protein. The invention also relates to methods of treatment of atherosclerosis, obesity, restenosis, coronary heart disease, hyperlipoproteinemia, hypercholesterolemia, and
The invention relates to compounds that are inhibitors of microsomal triglyceride transfer protein (MTP), to pharmaceutical compositions comprising them, and to the use thereof in medicine.
MTP (microsomal triglyceride transfer protein) is a transfer protein located in the reticulum of hepatocytes
FIELD OF INVENTION
The present invention relates to methods for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis in mammals by ingesting a stabilized rice bran derivative.
BACKGROUND OF THE INVENTION
Hypercholesterolemia is a condition with elevated levels of circulating total
FIELD OF INVENTION
The present invention relates to methods for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis in mammals by ingesting a stabilized rice bran derivative.
BACKGROUND OF THE INVENTION
Hypercholesterolemia is a condition with elevated levels of circulating total
FIELD OF INVENTION
The present invention relates to methods for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis in mammals by ingesting a stabilized rice bran derivative.
BACKGROUND OF THE INVENTION
Hypercholesterolemia is a condition with elevated levels of circulating total
1. Field of Invention
The present invention relates to methods for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis in mammals by ingesting a stabilized rice bran derivative.
2. Background of the Invention
Hypercholesterolemia is a condition with elevated levels of circulating
FIELD OF INVENTION
The present invention relates to novel hypolipidaemic and hypocholesterolemic compounds, their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and
FIELD
The invention relates generally to the fields of biochemistry, cell biology, molecular genetics, endocrinology, and cardiovascular medicine.
BACKGROUND
Contemporary Western type diets challenge lipid and glucose homeostasis by overloading blood with cholesterol, triglycerides, and glucose.